Duvall Diantha 5
5 · GENOCEA BIOSCIENCES, INC. · Filed Mar 16, 2022
Insider Transaction Report
Form 5
Duvall Diantha
CHIEF FINANCIAL OFFICER
Transactions
- Sale
Common Stock
2021-04-02$2.71/sh−925$2,507→ 62,997 total - Sale
Common Stock
2021-06-01$2.23/sh−511$1,140→ 62,486 total
Footnotes (1)
- [F1]Sale of shares by the Reporting Person to cover personal income tax withholding obligations in connection with the vesting and settlement of restricted stock units. Sell-to-cover is required by the Issuer, and this sale does not represent a discretionary transaction by the Reporting Person.